John Milligan
Chairman en PACIFIC BIOSCIENCES OF CALIFORNIA, INC. .
Fortuna: 4 M $ al 31/03/2024
Perfil
El Dr. John F. Milligan es presidente ejecutivo de 4D Molecular Therapeutics, Inc. y presidente de Pacific Biosciences of California, Inc. Forma parte del Consejo de Administración de la Biotechnology Innovation Organization y de la Ohio Wesleyan University. Anteriormente, el Dr. Milligan fue presidente de Pharmasset, Inc., director de gestión de proyectos de Hoffmann-La Roche, Inc. y presidente, consejero delegado y director de Gilead Sciences, Inc. Se licenció en la Universidad Wesleyan de Ohio y se doctoró en la Universidad de Illinois.
Participaciones conocidas en empresas públicas
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 03/04/2024 | 100 000 ( 0.20% ) | 3 M $ | 31/03/2024 | |
| 31/03/2024 | 110 000 ( 0.04% ) | 412 500 $ | 31/03/2024 |
Cargos activos de John Milligan
| Empresas | Cargo | Inicio |
|---|---|---|
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Chairman | 14/09/2020 |
| 4D MOLECULAR THERAPEUTICS, INC. | Chairman | 01/08/2020 |
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Director/Board Member | 22/07/2011 |
| Ohio Wesleyan University | Chairman | - |
Antiguos cargos conocidos de John Milligan.
| Empresas | Cargo | Fin |
|---|---|---|
| GILEAD SCIENCES, INC. | Chief Executive Officer | 31/12/2018 |
Pharmasset, Inc.
 Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | President | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Formación de John Milligan.
| Ohio Wesleyan University | Undergraduate Degree |
| University of Illinois | Doctorate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas cotizadas | 3 |
|---|---|
| GILEAD SCIENCES, INC. | Health Technology |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. | Health Technology |
| 4D MOLECULAR THERAPEUTICS, INC. | Health Technology |
| Empresas privadas | 3 |
|---|---|
Pharmasset, Inc.
Pharmasset, Inc. Pharmaceuticals: OtherHealth Technology Pharmasset, Inc. developed drugs to treat viral infections. It focued in the development of oral therapeutics for the treatment of hepatitis C virus (HCV) infection. The company was founded in 1998 and was headquartered in Princeton, NJ. | Health Technology |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
- Bolsa de valores
- Insiders
- John Milligan
